Transdermal, Topical & Subcutaneous Drug Delivery: Extending Pipelines & Improving Self-Administration


Drug Developments and Delivery

The global aging population is set to increase from 784 million in 2011 to 2 billion by 2050 and 2.8 billion by 2100. An increase in the number of geriatric patients and a rise in demand for convenient drug delivery options pose major opportunities for the development of innovative and easy-to-use drug delivery systems. These factors are giving rise to a new generation of transdermal, topical, and subcutaneous drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. This article includes a discussion about Adhesives Research’s skin-friendly adhesives for bonding body-worn devices.

Read Full Story: Drug Developments and Delivery